SB
Sandip Bhikaji Tawde
About Sandip Bhikaji Tawde
Data last updated:
Sandip Bhikaji Tawde is a Director at Sachio Pharma Bangalore Private Limited (since 2021) and Director at Sumire Lifesciences Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Sachio Pharma Bangalore Private Limited at ₹6.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sachio Pharma Bangalore Private Limited U51101MH2013PTC428114 | Director | 09 Jul 2021 | 2013 | ₹6.25 Cr (FY 2024) | Active |
| Sumire Lifesciences Private Limited U46497MH2023PTC408294 | Director | 09 Aug 2023 | 2023 | Active |
Board colleagues of Sandip Bhikaji Tawde
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sohini Sandip Tawde | 09232462 | Sachio Pharma Bangalore Private Limited , Sumire Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandip Bhikaji Tawde
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandip Bhikaji Tawde
Sandip Bhikaji Tawde currently holds 2 directorships: Sachio Pharma Bangalore Private Limited (Director, since 09 Jul 2021, revenue ₹6.25 Cr (FY 2024)); Sumire Lifesciences Private Limited (Director, since 09 Aug 2023).
Sandip Bhikaji Tawde was first appointed on 09 Jul 2021 as Director at Sachio Pharma Bangalore Private Limited. The most recent appointment on record is 09 Aug 2023 at Sumire Lifesciences Private Limited.
The current boards of Sandip Bhikaji Tawde's companies include Sohini Sandip Tawde (Sachio Pharma Bangalore Private Limited).